Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Nurses and AI artificial intelligence

4 ways to help nurses make friends with algorithms

Nurses tend to feel optimistic if not exactly excited about AI’s advances into their profession. Those who hold back tend to share a common concern—sacrificing care quality for the sake of tech-enabled efficiency. 

U.S. News & World Report children’s hospitals cardiology heart surgery

SCAI urges lawmakers to improve cardiac care access for children

The Accelerating Kids' Access to Care Act would expand Medicaid access for pediatric patients so that it covers interventional cardiologists outside of their home states.

big pharma ai artificial intelligence

In pharma, AI will probably make the big even bigger

Generative AI is fixing to transform the pharmaceutical industry. However, not all adopters will reap rewards in comparable degrees.  

AI in healthcare

Said and heard this week in and around healthcare

10 notable quotes about AI from the past 5 days.

Medicare data stethoscope healthcare trends graphs finance financials

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

artificial intelligence AI in the C suite

It’s 2024. Does the C-suite know—or care—what workers are doing with generative AI?

In the rush to do something, anything with AI, are America’s business leaders playing fast and loose with the risks? 

Thumbnail

Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Around the web

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Trimed Popup
Trimed Popup